LOBS INTERNATIONAL HEALTH : revenue, balance sheet and financial ratios

LOBS INTERNATIONAL HEALTH is a French company founded 25 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in BOULOGNE-BILLANCOURT (92100), this company of category PME shows in 2021 a revenue of 3.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LOBS INTERNATIONAL HEALTH (SIREN 434422689)
Indicator 2022 2021 2020 2016 2015
Revenue N/C 3 799 782 € N/C 4 951 960 € 4 278 493 €
Net income 717 433 € 588 012 € 831 630 € 478 624 € 216 628 €
EBITDA N/C 622 860 € N/C 791 121 € 341 207 €
Net margin N/C 15.5% N/C 9.7% 5.1%

Revenue and income statement

In 2022, LOBS INTERNATIONAL HEALTH generates positive net income of 717 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2022: 217 k€ -> 717 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

717 433 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

3.505%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

79.968%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

47.3%

Solvency indicators evolution
LOBS INTERNATIONAL HEALTH

Sector positioning

Debt ratio
3.5 2022
2020
2021
2022
Q1: 0.0
Med: 6.23
Q3: 53.97
Good +11 pts over 3 years

In 2022, the debt ratio of LOBS INTERNATIONAL HEALTH (3.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
79.97% 2022
2020
2021
2022
Q1: 15.33%
Med: 37.18%
Q3: 59.34%
Excellent

In 2022, the financial autonomy of LOBS INTERNATIONAL HEALTH (80.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.26 years 2021
2021
Q1: 0.0 years
Med: 0.01 years
Q3: 1.79 years
Average

In 2021, the repayment capacity of LOBS INTERNATIONAL HEALTH (0.26) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 716.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

716.57

Liquidity indicators evolution
LOBS INTERNATIONAL HEALTH

Sector positioning

Liquidity ratio
716.57 2022
2020
2021
2022
Q1: 136.77
Med: 203.41
Q3: 332.18
Excellent

In 2022, the liquidity ratio of LOBS INTERNATIONAL HEALTH (716.57) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
3.19x 2021
2021
Q1: 0.0x
Med: 0.39x
Q3: 4.57x
Good

In 2021, the interest coverage of LOBS INTERNATIONAL HEALTH (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LOBS INTERNATIONAL HEALTH

Positioning of LOBS INTERNATIONAL HEALTH in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of LOBS INTERNATIONAL HEALTH is estimated at 589 382 € (range 224 323€ - 2 152 349€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
124 transactions
224k€ 589k€ 2152k€
589 382 € Range: 224 323€ - 2 152 349€
NAF 5 all-time

Valuation method used

Net Income Multiple
717 433 € × 0.8x = 589 382 €
Range: 224 323€ - 2 152 350€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare LOBS INTERNATIONAL HEALTH with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about LOBS INTERNATIONAL HEALTH

What is the revenue of LOBS INTERNATIONAL HEALTH ?

The revenue of LOBS INTERNATIONAL HEALTH in 2021 is 3.8 M€.

Is LOBS INTERNATIONAL HEALTH profitable?

Yes, LOBS INTERNATIONAL HEALTH generated a net profit of 717 k€ in 2022.

Where is the headquarters of LOBS INTERNATIONAL HEALTH ?

The headquarters of LOBS INTERNATIONAL HEALTH is located in BOULOGNE-BILLANCOURT (92100), in the department Hauts-de-Seine.

Where to find the tax return of LOBS INTERNATIONAL HEALTH ?

The tax return of LOBS INTERNATIONAL HEALTH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LOBS INTERNATIONAL HEALTH operate?

LOBS INTERNATIONAL HEALTH operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.